Regeneron Pharmaceuticals Inc. buy Citigroup Inc.
Start price
14.05.25
/
50%
€519.80
Target price
14.05.26
€625.59
Performance (%)
17.99%
End price
15.05.26
€613.30
Summary
This prediction ended on 15.05.26 with a price of €613.30. The BUY prediction by Citigroup_Inc_ finished with a performance of 17.99%. Citigroup_Inc_ has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. A total of €3.58 was paid as dividends for this prediction. Citigroup_Inc_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 2.374% | 2.374% | 39.972% |
| iShares Core DAX® | 0,44 % | 5,90 % | 8,05 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % | 28,47 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % | 47,57 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 23,20 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $700.00 price target on the stock, up previously from $600.00.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€478.90
13.10.25
13.10.25
€568.00
13.10.26
13.10.26
44.43%
12:56
12:56
Stopped prediction by Citigroup_Inc_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€562.80
29.10.25
29.10.25
€600.95
29.10.26
29.10.26
22.90%
12:56
12:56
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€428.20
02.06.25
02.06.25
€571.68
02.06.26
02.06.26
19.83%
03.06.26
03.06.26